ICON Operating Income 2010-2025 | ICLR
ICON annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- ICON operating income for the quarter ending March 31, 2025 was $0.220B, a 23.1% decline year-over-year.
- ICON operating income for the twelve months ending March 31, 2025 was $1.032B, a 0.68% increase year-over-year.
- ICON annual operating income for 2024 was $1.098B, a 14.82% increase from 2023.
- ICON annual operating income for 2023 was $0.956B, a 20.23% increase from 2022.
- ICON annual operating income for 2022 was $0.795B, a 110.09% increase from 2021.
| ICON Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $1,098 |
| 2023 | $956 |
| 2022 | $795 |
| 2021 | $379 |
| 2020 | $392 |
| 2019 | $433 |
| 2018 | $373 |
| 2017 | $338 |
| 2016 | $312 |
| 2015 | $282 |
| 2014 | $202 |
| 2013 | $121 |
| 2012 | $68 |
| 2011 | $39 |
| 2010 | $92 |
| 2009 | $116 |
| ICON Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $220 |
| 2024-12-31 | $297 |
| 2024-09-30 | $285 |
| 2024-06-30 | $230 |
| 2024-03-31 | $285 |
| 2023-12-31 | $266 |
| 2023-09-30 | $264 |
| 2023-06-30 | $209 |
| 2023-03-31 | $217 |
| 2022-12-31 | $203 |
| 2022-09-30 | $244 |
| 2022-06-30 | $178 |
| 2022-03-31 | $170 |
| 2021-12-31 | $145 |
| 2021-09-30 | $5 |
| 2021-06-30 | $113 |
| 2021-03-31 | $116 |
| 2020-12-31 | $120 |
| 2020-09-30 | $108 |
| 2020-06-30 | $57 |
| 2020-03-31 | $106 |
| 2019-12-31 | $115 |
| 2019-09-30 | $110 |
| 2019-06-30 | $106 |
| 2019-03-31 | $102 |
| 2018-12-31 | $102 |
| 2018-09-30 | $98 |
| 2018-06-30 | $82 |
| 2018-03-31 | $92 |
| 2017-12-31 | $90 |
| 2017-09-30 | $85 |
| 2017-06-30 | $78 |
| 2017-03-31 | $86 |
| 2016-12-31 | $85 |
| 2016-09-30 | $77 |
| 2016-06-30 | $74 |
| 2016-03-31 | $76 |
| 2015-12-31 | $75 |
| 2015-09-30 | $71 |
| 2015-06-30 | $68 |
| 2015-03-31 | $67 |
| 2014-12-31 | $52 |
| 2014-09-30 | $59 |
| 2014-06-30 | $48 |
| 2014-03-31 | $43 |
| 2013-12-31 | $30 |
| 2013-09-30 | $33 |
| 2013-06-30 | $31 |
| 2013-03-31 | $130 |
| 2012-12-31 | $19 |
| 2012-09-30 | $21 |
| 2012-06-30 | $17 |
| 2012-03-31 | $102 |
| 2011-12-31 | $7 |
| 2011-09-30 | $1 |
| 2011-06-30 | $16 |
| 2011-03-31 | $92 |
| 2010-12-31 | $112 |
| 2010-09-30 | $18 |
| 2010-06-30 | $26 |
| 2010-03-31 | $27 |
| 2009-12-31 | $30 |
| 2009-09-30 | $30 |
| 2009-06-30 | $29 |
| 2009-03-31 | $27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.996B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.323B | 26.51 |
| CVS Health (CVS) | United States | $85.490B | 10.63 |
| Elevance Health (ELV) | United States | $85.046B | 10.97 |
| Cencora (COR) | United States | $57.007B | 19.83 |
| Natera (NTRA) | United States | $23.468B | 0.00 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Labcorp Holdings (LH) | United States | $21.974B | 17.82 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.262B | 0.00 |
| Solventum (SOLV) | United States | $12.973B | 13.73 |
| CochLear (CHEOY) | Australia | $12.633B | 0.00 |
| Revvity (RVTY) | United States | $11.361B | 19.55 |
| Viatris (VTRS) | United States | $10.504B | 3.61 |
| Avantor (AVTR) | United States | $9.172B | 13.33 |
| Medpace Holdings (MEDP) | United States | $9.062B | 24.07 |
| HealthEquity (HQY) | United States | $9.009B | 39.46 |
| Sonic Healthcare (SKHHY) | Australia | $8.263B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.289B | 14.28 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.259B | 25.08 |
| BrightSpring Health Services (BTSG) | United States | $4.024B | 36.92 |
| Sotera Health (SHC) | United States | $3.191B | 18.13 |
| Alignment Healthcare (ALHC) | United States | $2.786B | 0.00 |
| Concentras Parent (CON) | United States | $2.716B | 15.70 |
| Surgery Partners (SGRY) | United States | $2.705B | 35.18 |
| GeneDx Holdings (WGS) | United States | $2.594B | 99.89 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| PACS (PACS) | United States | $1.928B | 0.00 |
| Ardent Health (ARDT) | United States | $1.887B | 8.04 |
| Progyny (PGNY) | United States | $1.822B | 40.11 |
| GoodRx Holdings (GDRX) | United States | $1.811B | 36.21 |
| Premier (PINC) | United States | $1.791B | 13.59 |
| Teladoc Health (TDOC) | United States | $1.403B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.158B | 8.81 |
| CareDx (CDNA) | United States | $1.051B | 16.42 |
| Establishment Labs Holdings (ESTA) | $1.034B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.915B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.831B | 7.78 |
| Nutex Health (NUTX) | United States | $0.641B | 9.70 |
| LifeMD (LFMD) | United States | $0.639B | 0.00 |
| Embecta (EMBC) | United States | $0.597B | 4.02 |
| InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Omada Health (OMDA) | $0.404B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.237B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 28.83 |
| So-Young (SY) | China | $0.174B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.123B | 0.00 |
| OncoCyte (IMDX) | United States | $0.099B | 0.00 |
| KindlyMD (NAKA) | United States | $0.092B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |